Point Mutations of the Mxil Gene are Rare in Prostate Cancers
β Scribed by Norihiko Kawamata; Dorothy Park; Sharon Wilczynski; Jun Yokota; H. Phillip Koeffler
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 268 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Distal colorectal cancers, especially those in the rectum, are more aggressive and more commonly recurrent than proximal cancers. We studied the possible relationship between p53-gene mutation type and location of the tumour, since mutations in the conserved areas of the p53 gene have been suggested
BACKGROUND. p53 is the most highly mutated tumor suppressor gene in human cancers. Recently, p73, a first homologue of p53, was identified and considered to be an imprinted tumor suppressor gene. Thus, we analyzed the possible role of p73 in human prostate cancers. METHODS. We investigated the expre
One of the most common chromosomal abnormalities in prostate cancer involves loss of 10q22-qter. Rarely, a smaller deletion, involving 10q24-q25, has been observed, suggesting the presence of a tumor suppressor gene at this site. We previously demonstrated that the MXI1 gene maps to 10q24-q25 and is
BACKGROUND. Loss of heterozygosity (LOH) on chromosome arm 18q is common in sporadic prostate cancer and may be involved in cancer development through inactivation of tumor-suppressor genes (TSG). Recent identification, at 18q21.1, of MADR2/Smad2, a key component in transforming growth factor β€ (TGF